Chinese herbal experience for the 2019 novel coronavirus

Crit Care. 2020 Jul 21;24(1):451. doi: 10.1186/s13054-020-03170-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • COVID-19
  • China / epidemiology
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Treatment Outcome

Substances

  • Drugs, Chinese Herbal